Biofrontera elects Hoffman & Weber as directors, ratifies Marcum as auditor

Biofrontera Inc.

Elected Beth J. Hoffman (531,471 for) and Kevin D. Weber (531,796 for) as Class II directors for terms ending 2026.
Ratified Marcum LLP as independent auditor for FY 2023 (878,777 for, 2,734 against, 2,256 abstain).
Annual Meeting quorum: 883,767 shares (58.2% of 1,517,628 outstanding) present on Dec 20, 2023.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Biofrontera Inc. shareholders approved Ratification of Appointment of Independent Public Accounting Firm (Marcum LLP) at the 2023-12-20 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-12-20

Exact text from the filing

Ratification of Appointment of Independent Public Accounting Firm For Against Abstain Broker Non-Votes 878,777 2,734 2,256 N/A

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Biofrontera Inc. shareholders approved Election of Beth J. Hoffman, Ph.D. and Kevin D. Weber as Class II Directors at the 2023-12-20 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-12-20

Exact text from the filing

Beth J. Hoffman, Ph.D. For Withheld Broker Non-Votes 531,471 9,810 342,486

View on SEC.gov

Browse all shareholder votes →

Biofrontera Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-046279

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.